表紙:核酸単離・精製の市場動向・市場シェア・市場規模の予測 (2021-2028年):製品 (機器・キット・試薬)・タイプ・用途・手法 (カラム・磁気)・エンドユーザー・地域別
市場調査レポート
商品コード
999538

核酸単離・精製の市場動向・市場シェア・市場規模の予測 (2021-2028年):製品 (機器・キット・試薬)・タイプ・用途・手法 (カラム・磁気)・エンドユーザー・地域別

Nucleic Acid Isolation And Purification Market Size, Share & Trends Analysis Report By Product (Instruments, Kits & Reagents), By Type, By Application, By Method (Column-based, Magnetic Beads), By End-use, By Region, And Segment Forecasts, 2021-2028

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 175 Pages | 納期: 2-10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.41円
核酸単離・精製の市場動向・市場シェア・市場規模の予測 (2021-2028年):製品 (機器・キット・試薬)・タイプ・用途・手法 (カラム・磁気)・エンドユーザー・地域別
出版日: 2021年03月15日
発行: Grand View Research, Inc.
ページ情報: 英文 175 Pages
納期: 2-10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の核酸単離・精製の市場規模は予測期間中11.4%のCAGRで推移し、2028年には98億米ドルの規模に成長すると予測されています。

分子検出プラットフォームの技術的進歩が同市場の成長を推進しています。自動DNA抽出システムにおけるロボットリキッドハンドリングなどの技術により、プロセスフローが改善されています。このような自動化により、サンプルからのDNA抽出、連続希釈、目的の遺伝子のピックアップなど、さまざまなプロセスに関わるすべてのタスクが合理化されています。

当レポートでは、世界の核酸単離・精製の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、技術動向、アウトソーシング・受託製造の動向、市場規模の推移・予測、製品・タイプ・手法・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 市場可変因子・動向・展望

  • 市場の見通し
  • 技術動向
  • アウトソーシング・受託製造の動向
  • 市場力学
  • 普及・成長の見通しマッピング
  • COVID-19:影響分析
  • 事業環境の分析
  • 主な取引・戦略的提携の分析

第4章 市場分析・予測:製品別

  • キット・試薬
  • 機器

第5章 市場分析・予測:タイプ別

  • DNA分離・精製
  • RNA分離・精製

第6章 市場分析・予測:手法別

  • カラム
  • 磁気ビーズ
  • 試薬
  • その他

第7章 市場分析・予測:用途別

  • 精密医療
  • 診断
  • 創薬・開発
  • 農業・動物研究
  • その他

第8章 市場分析・予測:エンドユーザー別

  • 学術研究機関
  • 製薬・バイオテクノロジー企業
  • CRO
  • 病院・診断センター
  • その他

第9章 市場分析・予測:地域別

  • 市場シェア実績・予測
  • 市場予測
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 企業の分類
  • 戦略的枠組み
  • 競合環境
  • 公開企業
  • 非公開企業
  • 企業プロファイル
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • Illumina Inc
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd.
    • Merck KGaA
    • Agilent Technologies
    • Bio-Rad Laboratories, Inc.
    • TAKARA BIO, INC.
    • Promega Corporation
    • New England Biolabs
    • LGC Limited
    • Abcam plc
    • Norgen Biotek Corp.
    • AUTOGEN. INC.
    • Biogenuix
    • PCR Biosystems, Inc.
    • MagGenome
    • Axon Scientific Sdn. Bhd./ Apical Scientific Sdn. Bhd.
    • MACHEREY-NAGEL GmbH & Co. KG
図表

List of Tables

  • Table 1 Product portfolio analysis
  • Table 2 Comparison of magnetic bead surface chemistries and applications
  • Table 3 Use of nucleic acid isolation and purification techniques across various aspects of disease management
  • Table 4 Sequencing-related preparation procedures and their use
  • Table 5 Automated nucleic acid extraction systems
  • Table 6 Challenges associated with sample preparation
  • Table 7 Specifications of the four automated extraction robots evaluated for extracting clinically relevant amounts of A. fumigatus conidia direct from spore suspension
  • Table 8 Time and cost per extraction of some automated nucleic acid systems
  • Table 9 Use of nucleic acid isolation and purification techniques across various aspects of disease management
  • Table 10 Sequencing-related preparation procedures and their use
  • Table 11 North America nucleic acid isolation & purification market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 12 North America nucleic acid isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 13 North America DNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 14 North America RNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 15 North America nucleic acid isolation & purification market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 16 North America nucleic acid isolation & purification market estimates & forecasts, by method, 2017 - 2028 (USD Million)
  • Table 17 North America nucleic acid isolation & purification market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
  • Table 18 U.S. nucleic acid isolation & purification market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 19 U.S. nucleic acid isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 20 U.S. DNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 21 U.S. RNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 22 U.S. nucleic acid isolation & purification market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 23 U.S. nucleic acid isolation & purification market estimates & forecasts, by method, 2017 - 2028 (USD Million)
  • Table 24 U.S. nucleic acid isolation & purification market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
  • Table 25 Canada nucleic acid isolation & purification market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 26 Canada nucleic acid isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 27 Canada DNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 28 Canada RNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 29 Canada nucleic acid isolation & purification market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 30 Canada nucleic acid isolation & purification market estimates & forecasts, by method, 2017 - 2028 (USD Million)
  • Table 31 Canada nucleic acid isolation & purification market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
  • Table 32 Europe nucleic acid isolation & purification market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 33 Europe nucleic acid isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 34 Europe DNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 35 Europe RNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 36 Europe nucleic acid isolation & purification market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 37 Europe nucleic acid isolation & purification market estimates & forecasts, by method, 2017 - 2028 (USD Million)
  • Table 38 Europe nucleic acid isolation & purification market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
  • Table 39 Germany nucleic acid isolation & purification market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 40 Germany nucleic acid isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 41 Germany DNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 42 Germany RNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 43 Germany nucleic acid isolation & purification market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 44 Germany nucleic acid isolation & purification market estimates & forecasts, by method, 2017 - 2028 (USD Million)
  • Table 45 Germany nucleic acid isolation & purification market estimates & forecasts, by en use, 2017 - 2028 (USD Million)
  • Table 46 U.K. nucleic acid isolation & purification market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 47 U.K. nucleic acid isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 48 U.K. DNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 49 U.K. RNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 50 U.K. nucleic acid isolation & purification market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 51 U.K. nucleic acid isolation & purification market estimates & forecasts, by method, 2017 - 2028 (USD Million)
  • Table 52 U.K. nucleic acid isolation & purification market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
  • Table 53 Asia Pacific nucleic acid isolation & purification market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 54 Asia Pacific nucleic acid isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 55 Asia Pacific DNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 56 Asia Pacific RNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 57 Asia Pacific nucleic acid isolation & purification market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 58 Asia Pacific nucleic acid isolation & purification market estimates & forecasts, by method, 2017 - 2028 (USD Million)
  • Table 59 Asia Pacific nucleic acid isolation & purification market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
  • Table 60 Japan nucleic acid isolation & purification market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 61 Japan nucleic acid isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 62 Japan DNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 63 Japan RNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 64 Japan nucleic acid isolation & purification market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 65 Japan nucleic acid isolation & purification market estimates & forecasts, by method, 2017 - 2028 (USD Million)
  • Table 66 Japan nucleic acid isolation & purification market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
  • Table 67 China nucleic acid isolation & purification market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 68 China nucleic acid isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 69 China DNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 70 China RNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 71 China nucleic acid isolation & purification market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 72 China nucleic acid isolation & purification market estimates & forecasts, by method, 2017 - 2028 (USD Million)
  • Table 73 China nucleic acid isolation & purification market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
  • Table 74 Latin America nucleic acid isolation & purification market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 75 Latin America nucleic acid isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 76 Latin America DNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 77 Latin America RNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 78 Latin America nucleic acid isolation & purification market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 79 Latin America nucleic acid isolation & purification market estimates & forecasts, by method, 2017 - 2028 (USD Million)
  • Table 80 Latin America nucleic acid isolation & purification market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
  • Table 81 Brazil nucleic acid isolation & purification market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 82 Brazil nucleic acid isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 83 Brazil DNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 84 Brazil RNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 85 Brazil nucleic acid isolation & purification market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 86 Brazil nucleic acid isolation & purification market estimates & forecasts, by method, 2017 - 2028 (USD Million)
  • Table 87 Brazil nucleic acid isolation & purification market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
  • Table 88 Mexico nucleic acid isolation & purification market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 89 Mexico nucleic acid isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 90 Mexico DNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 91 Mexico RNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 92 Mexico nucleic acid isolation & purification market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 93 Mexico nucleic acid isolation & purification market estimates & forecasts, by method, 2017 - 2028 (USD Million)
  • Table 94 Mexico nucleic acid isolation & purification market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
  • Table 95 MEA nucleic acid isolation & purification market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 96 MEA nucleic acid isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 97 MEA DNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 98 MEA RNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 99 MEA nucleic acid isolation & purification market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 100 MEA nucleic acid isolation & purification market estimates & forecasts, by method, 2017 - 2028 (USD Million)
  • Table 101 MEA nucleic acid isolation & purification market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
  • Table 102 South Africa nucleic acid isolation & purification market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • Table 103 South Africa nucleic acid isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 104 South Africa DNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 105 South Africa RNA isolation & purification market estimates & forecasts, by type, 2017 - 2028 (USD Million)
  • Table 106 South Africa nucleic acid isolation & purification market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • Table 107 South Africa nucleic acid isolation & purification market estimates & forecasts, by method, 2017 - 2028 (USD Million)
  • Table 108 South Africa nucleic acid isolation & purification market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
  • Table 109 List of key emerging companies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Geographical distribution of primary interviews
  • Fig. 5 Executives contacted
  • Fig. 6 Distribution of key participants, by region
  • Fig. 7 Market research approaches
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modeling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Ancillary market analysis
  • Fig. 12 Genetic analysis techniques market share analysis
  • Fig. 13 Commodity flow analysis modelling for products market
  • Fig. 14 Comparative analysis of different methods based on commercial availability, product, and cost
  • Fig. 15 Summary of available devices used in nucleic acid extraction protocols
  • Fig. 16 Typical yields of commercially available kits based on different methods
  • Fig. 17 Typical factors for the analysis of applications of nucleic acid isolation & purification
  • Fig. 18 Key drivers for the adoption of sample preparation technologies in end-use settings
  • Fig. 19 Country-wise sales (%) of key players
  • Fig. 20 Market segmentation & scope
  • Fig. 21 Market snapshot, 2020, (USD Million)
  • Fig. 22 Timeline for advancements of different DNA extraction techniques
  • Fig. 23 Market trends & outlook
  • Fig. 24 Market driver relevance analysis (Current & future impact)
  • Fig. 25 New cancer cases in women, 2020
  • Fig. 26 New cancer cases in men, 2020
  • Fig. 27 Average net new genetic testing units per day, as per Concert Genetics
  • Fig. 28 Total number of COVID-19 cases, by country
  • Fig. 29 Total number of deaths due to COVID-19, by country
  • Fig. 30 Number of COVID-19 tests performed, by country
  • Fig. 31 Market restraint analysis
  • Fig. 32 Market opportunity analysis
  • Fig. 33 Market challenge analysis
  • Fig. 34 Penetration & growth prospect mapping for method, 2020
  • Fig. 35 Workflow for relative quantification of SARS-CoV-2 RNA using qPCR
  • Fig. 36 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 37 Porter's Five Forces Analysis
  • Fig. 38 Nucleic acid isolation and purification market: Product outlook key takeaways
  • Fig. 39 Nucleic acid isolation and purification market: Product movement analysis
  • Fig. 40 Kits & reagents market, 2017 - 2028 (USD million)
  • Fig. 41 Instruments market, 2017 - 2028 (USD million)
  • Fig. 42 Nucleic acid isolation and purification market: Type outlook key takeaways
  • Fig. 43 Nucleic acid isolation and purification market: Type movement analysis
  • Fig. 44 DNA isolation & purification market, 2017 - 2028 (USD million)
  • Fig. 45 Genomic DNA isolation & purification market, 2017 - 2028 (USD million)
  • Fig. 46 gDNA isolation reagents and instruments market, by end use, 2017 - 2028 (USD Million)
  • Fig. 47 Plasmid DNA isolation & purification market, 2017 - 2028 (USD million)
  • Fig. 48 Plasmid DNA isolation reagents and instruments market, by end use, 2017 - 2028 (USD Million)
  • Fig. 49 Downstream applications of plasmid DNA in research
  • Fig. 50 Plasmid DNA kits market, by product, 2020 (%)
  • Fig. 51 Comparison of key plasmid DNA mini prep kits
  • Fig. 52 Comparison of key plasmid DNA midi prep kits
  • Fig. 53 Comparison of key plasmid DNA maxi prep kits
  • Fig. 54 Viral DNA isolation & purification market, 2017 - 2028 (USD million)
  • Fig. 55 Others market, 2017 - 2028 (USD million)
  • Fig. 56 RNA isolation & purification market, 2017 - 2028 (USD million)
  • Fig. 57 RNA isolation reagents and instruments market, by end use, 2017 - 2028 (USD Million)
  • Fig. 58 miRNA isolation & purification market, 2017 - 2028 (USD million)
  • Fig. 59 mRNA isolation & purification market, 2017 - 2028 (USD million)
  • Fig. 60 Total RNA isolation & purification market, 2017 - 2028 (USD million)
  • Fig. 61 Others market, 2017 - 2028 (USD million)
  • Fig. 62 Nucleic acid isolation and purification market: Method outlook key takeaways
  • Fig. 63 Nucleic acid isolation and purification market: Method movement analysis
  • Fig. 64 Column based market, 2017 - 2028 (USD million)
  • Fig. 65 Magnetic beads market, 2017 - 2028 (USD million)
  • Fig. 66 Reagent based market, 2017 - 2028 (USD million)
  • Fig. 67 Others market, 2017 - 2028 (USD million)
  • Fig. 68 Nucleic acid isolation and purification market Application outlook key takeaways
  • Fig. 69 Nucleic acid isolation and purification market: Application movement analysis
  • Fig. 70 Precision medicine market, 2017 - 2028 (USD million)
  • Fig. 71 Diagnostics market, 2017 - 2028 (USD million)
  • Fig. 72 Drug discovery & development market, 2017 - 2028 (USD million)
  • Fig. 73 Agriculture and animal research market, 2017 - 2028 (USD million)
  • Fig. 74 Other applications market, 2017 - 2028 (USD million)
  • Fig. 75 Nucleic acid isolation and purification market: End-use outlook key takeaways
  • Fig. 76 Penetration of nucleic acid isolation & purification market in downstream applications
  • Fig. 77 Nucleic acid isolation and purification market: End use movement analysis
  • Fig. 78 Academic research institutes market, 2017 - 2028 (USD million)
  • Fig. 79 Pharmaceutical & biotechnology companies market, 2017 - 2028 (USD million)
  • Fig. 80 Contract Research Organizations market, 2017 - 2028 (USD million)
  • Fig. 81 Hospitals and diagnostic centers market, 2017 - 2028 (USD million)
  • Fig. 82 Other end-use market, 2017 - 2028 (USD million)
  • Fig. 83 Regional marketplace: Key takeaway
  • Fig. 84 Nucleic acid isolation & purification market: Regional movement analysis
  • Fig. 85 North America market, 2017 - 2028 (USD million)
  • Fig. 86 Penetration of end-users in the U.S. market
  • Fig. 87 U.S. market, 2017 - 2028 (USD million)
  • Fig. 88 Canada market, 2017 - 2028 (USD million)
  • Fig. 89 Europe market, 2017 - 2028 (USD million)
  • Fig. 90 Germany market, 2017 - 2028 (USD million)
  • Fig. 91 U.K. market, 2017 - 2028 (USD million)
  • Fig. 92 Asia Pacific market, 2017 - 2028 (USD million)
  • Fig. 93 Japan market, 2017 - 2028 (USD million)
  • Fig. 94 China market, 2017 - 2028 (USD million)
  • Fig. 95 Latin America market, 2017 - 2028 (USD million)
  • Fig. 96 Brazil market, 2017 - 2028 (USD million)
  • Fig. 97 Mexico market, 2017 - 2028 (USD million)
  • Fig. 98 MEA market, 2017 - 2028 (USD million)
  • Fig. 99 South Africa market, 2017 - 2028 (USD million)
  • Fig. 100 Company categorization
  • Fig. 101 Strategy framework
  • Fig. 102 QIAsymphony cumulative placements
  • Fig. 103 Heat map analysis of top public companies
目次
Product Code: GVR-2-68038-580-9

Nucleic Acid Isolation And Purification Market Growth & Trends:

The global nucleic acid isolation and purification market size is anticipated to reach USD 9.8 billion by 2028, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.4% from 2021 to 2028. The growth can be primarily attributed to the technological advancements in molecular detection platforms. The technologies such as robotic liquid handling in automated DNA extraction systems, have improved the process flow. Such automation has streamlined all the tasks involved in various processes, such as DNA extraction from samples, serial dilution, and picking the desired gene of interest.

The outbreak of SARS-CoV-2 in late 2019 in China quickly translated into a global pandemic, which led to high demand for efficient and affordable diagnostic tests that could be carried out in non-clinical as well as clinical settings. This also led to high demand for nucleic acid extraction kits which in turn has led the key players to increase their manufacturing capabilities. For instance, in March 2020, QIAGEN announced the expansion of its production capacity in the U.S. and Europe to reach 20 million monthly patient tests by the end of 2020.

Moreover, rapid diagnosis, effective treatment options, and future prevention plans are essential in the management of COVID-19. The current race for the development of cost-effective, point-of-contact test kits and efficient laboratory methodologies for the detection of coronavirus infection has driven a new frontier of diagnostic innovation. The increase in adoption of PCR for SARS-CoV-2 detection by a wide range of commercial laboratories drives the market, as nucleic acid isolation and purification is an important step in the PCR workflow.

Nucleic Acid Isolation And Purification Market Report Highlights:

  • The kits and reagents segment accounted for the largest revenue share in 2020 owing to the rising number of research studies focused on understanding rare and common genome-based diseases
  • The RNA isolation and purification segment holds the largest revenue share in 2020 due to its increasing use for the analysis of COVID samples
  • The DNA isolation and purification segment is expected to witness the fastest growth rate owing to its use in a variety of molecular biology applications
  • The magnetic beads segment accounted for the largest revenue share in 2020 and is expected to continue the trend owing to the advantage of obtaining the purest possible form of DNA/RNA and excluding other unwanted materials from the sample mixture
  • The diagnostics segment dominated the market and accounted for the largest revenue share in 2020 owing to the high adoption of NAI and P products for detecting and characterizing microorganisms
  • The pharmaceutical and biotechnology companies are expected to witness the fastest growth owing to their increasing research and development activities for drug development
  • North America has emerged as the highest revenue-generating region due to intensive research projects in the region for cancer detection and other chronic disorders
  • Companies operating in the market are launching new and automated systems for nucleic acid isolation and purification. For instance, in March 2021, QIAGEN N.V. launched an automated sample processing system the QIAcube Connect MDx for molecular diagnostic laboratories
  • The system helps in the automation of several steps such as lysis, binding, washing, and elution for RNA, DNA, and protein sample processing

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Scope
    • 1.1.1 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
      • 1.3.3.1 List of secondary data sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
      • 1.3.5.1 Primary Interviews: Statistics
      • 1.3.5.1.1 Geographical distribution of primary interviews
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Parent & ancillary techniques
  • 1.7 Product Scope
    • 1.7.1 Definition
      • 1.7.1.1 Instruments
      • 1.7.1.2 Kits & reagents
    • 1.7.2 Market model
  • 1.8 Type Scope
    • 1.8.1 Definition
      • 1.8.1.1 DNA isolation & purification
      • 1.8.1.2 RNA isolation & purification
    • 1.8.2 Market model
  • 1.9 Method Scope
    • 1.9.1 Definition
      • 1.9.1.1 Column based
      • 1.9.1.2 Magnetic bead based
      • 1.9.1.3 Reagent based
      • 1.9.1.4 Others
    • 1.9.2 Market model
      • 1.9.2.1 By method
  • 1.10 Application Scope
    • 1.10.1 Definition
      • 1.10.1.1 Precision medicine
      • 1.10.1.2 Diagnostics
      • 1.10.1.3 Drug Discovery & Development
      • 1.10.1.4 Agriculture and Animal Research
      • 1.10.1.5 Other Applications
    • 1.10.2 Market model
  • 1.11 End-use Scope
    • 1.11.1 Definition
      • 1.11.1.1 Academic research institutes
      • 1.11.1.2 Pharmaceutical & biotechnology companies
      • 1.11.1.3 Contract research organizations
      • 1.11.1.4 Hospitals and diagnostic centers
      • 1.11.1.5 Other End-use
    • 1.11.2 Market model
  • 1.12 Regional Scope
    • 1.12.1 Region-wise market: Base estimates
  • 1.13 Objectives
    • 1.13.1 Objective 1:
    • 1.13.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Nucleic Acid Isolation And Purification Market: Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights
  • 2.4 Market Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent & ancillary market outlook
  • 3.2 Nucleic Acid Isolation & Purification Market: Technology Trends
    • 3.2.1 Technology trends
  • 3.3 Outsourcing & contract manufacturing trends
  • 3.4 Market Dynamics
    • 3.4.1 Market driver analysis
      • 3.4.1.1 Increasing incidence of cancer, genetic disorders, and infectious diseases
      • 3.4.1.2 Increase in public-private funding on biotechnology and life sciences research
      • 3.4.1.3 Advancements in automation
      • 3.4.1.4 Growth in NGS technologies
      • 3.4.1.5 Growing demand for genetically modified crops and organisms
    • 3.4.2 Market restraint analysis
      • 3.4.2.1 Expensive instruments and consequent low penetration in emerging countries
      • 3.4.2.2 Challenges related to the use of big data and bioinformatics
    • 3.4.3 Market opportunity analysis
      • 3.4.3.1 Automation in nucleic acid isolation and purification techniques
      • 3.4.3.2 Adoption of downstream applications of nucleic acid purification and isolation for COVID-19 diagnostics
    • 3.4.4 Market challenge analysis
      • 3.4.4.1 Challenges associated with sample preparation
  • 3.5 Penetration & Growth Prospect Mapping for Method, 2020
  • 3.6 COVID-19 Impact Analysis on Market
    • 3.6.1 Utilization of nucleic acid isolation and purification kits for analysis of COVID-19 samples
    • 3.6.2 Shortage of RNA isolation kits
    • 3.6.3 Increase in global production capacities
  • 3.7 BUSINESS ENVIRONMENT ANALYSIS
    • 3.7.1 Nucleic Acid Isolation & Purification Market - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
    • 3.7.2 Porter's Five Forces Analysis
  • 3.8 Major Deals & Strategic Alliances Analysis
    • 3.8.1 Product developments
    • 3.8.2 Merger & acquisition
    • 3.8.3 Agreement
    • 3.8.4 Collaboration & partnership

Chapter 4 Product Business Analysis

  • 4.1 Nucleic Acid Isolation and Purification Market: Product Movement Analysis
  • 4.2 Kits & Reagents
    • 4.2.1 Kits & reagents market estimates and forecasts, 2017 - 2028 (USD Million)
  • 4.3 Instruments
    • 4.3.1 Instruments market estimates and forecasts, 2017 - 2028 (USD Million)

Chapter 5 Type Business Analysis

  • 5.1 Nucleic Acid Isolation and Purification Market: Type Movement Analysis
  • 5.2 DNA Isolation & Purification
    • 5.2.1 DNA isolation & purification market estimates and forecasts, 2017 - 2028 (USD Million)
    • 5.2.2 Genomic DNA isolation & purification
      • 5.2.2.1 Genomic DNA isolation & purification market estimates and forecasts, 2017 - 2028 (USD Million)
    • 5.2.3 Plasmid DNA isolation & purification
      • 5.2.3.1 Plasmid DNA isolation & purification market estimates and forecasts, 2017 - 2028 (USD Million)
    • 5.2.4 Viral DNA isolation & purification
      • 5.2.4.1 Viral DNA isolation & purification market estimates and forecasts, 2017 - 2028 (USD Million)
    • 5.2.5 Other types
      • 5.2.5.1 Others market estimates and forecasts, 2017 - 2028 (USD Million)
  • 5.3 RNA Isolation & Purification
    • 5.3.1 RNA isolation & purification market estimates and forecasts, 2017 - 2028 (USD Million)
    • 5.3.2 RNA Isolation Reagents and Instruments Market, By End Use
      • 5.3.2.1 Manufacturing/bioprocessing
      • 5.3.2.2 Research
      • 5.3.2.3 Clinical/diagnostics
    • 5.3.3 miRNA isolation and purification
      • 5.3.3.1 miRNA isolation & purification market estimates and forecasts, 2017 - 2028 (USD Million)
    • 5.3.4 mRNA isolation & purification
      • 5.3.4.1 mRNA isolation & purification market estimates and forecasts, 2017 - 2028 (USD Million)
    • 5.3.5 Total RNA isolation & purification
      • 5.3.5.1 Total RNA isolation & purification market estimates and forecasts, 2017 - 2028 (USD Million)
    • 5.3.6 Other types
      • 5.3.6.1 Others market estimates and forecasts, 2017 - 2028 (USD Million)

Chapter 6 Method Business Analysis

  • 6.1 Nucleic Acid Isolation and Purification Market: Method Movement Analysis
  • 6.2 Column Based Isolation & Purification
    • 6.2.1 Column based market estimates and forecasts, 2017 - 2028 (USD Million)
  • 6.3 Magnetic Bead Based Isolation & Purification
    • 6.3.1 Magnetic beads market estimates and forecasts, 2017 - 2028 (USD Million)
  • 6.4 Reagent Based Isolation & Purification
    • 6.4.1 Reagent based market estimates and forecasts, 2017 - 2028 (USD Million)
  • 6.5 Other Methods
    • 6.5.1 Others market estimates and forecasts, 2017 - 2028 (USD Million)

Chapter 7 Application Business Analysis

  • 7.1 Nucleic Acid Isolation and Purification Market: Application Movement Analysis
  • 7.2 Precision Medicine
    • 7.2.1 Precision medicine market estimates and forecasts, 2017 - 2028 (USD Million)
  • 7.3 Diagnostics
    • 7.3.1 Diagnostics market estimates and forecasts, 2017 - 2028 (USD Million)
  • 7.4 Drug Discovery & Development
    • 7.4.1 Drug discovery & development market estimates and forecasts, 2017 - 2028 (USD Million)
  • 7.5 Agriculture & Animal Research
    • 7.5.1 Agriculture and animal research market estimates and forecasts, 2017 - 2028 (USD Million)
  • 7.6 Other Applications
    • 7.6.1 Other applications market estimates and forecasts, 2017 - 2028 (USD Million)

Chapter 8 End-use Business Analysis

  • 8.1 Nucleic Acid Isolation and Purification Market: End-use Movement Analysis
    • 8.1.1 Application Scope: Test Type Penetration
  • 8.2 Academic Research Institutes
    • 8.2.1 Academic research institutes market estimates and forecasts, 2017 - 2028 (USD Million)
  • 8.3 Pharmaceutical & Biotechnology Companies
    • 8.3.1 Pharmaceutical & biotechnology companies market estimates and forecasts, 2017 - 2028 (USD Million)
  • 8.4 Contract Research Organizations
    • 8.4.1 Contract Research Organizations market estimates and forecasts, 2017 - 2028 (USD Million)
  • 8.5 Hospitals and Diagnostic Centers
    • 8.5.1 Hospitals and diagnostic centers market estimates and forecasts, 2017 - 2028 (USD Million)
  • 8.6 Other End-use
    • 8.6.1 Other end-use market estimates and forecasts, 2017 - 2028 (USD Million)

Chapter 9 Regional Business Analysis

  • 9.1 Nucleic Acid Isolation & Purification Market Share By Region, 2020 & 2028
  • 9.2 North America
    • 9.2.1 North America market estimates and forecasts, 2017 - 2028 (USD Million)
    • 9.2.2 U.S.
      • 9.2.2.1 U.S. nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
      • 9.2.2.2 U.S. nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
      • 9.2.2.3 U.S. nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
      • 9.2.2.4 U.S. nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
      • 9.2.2.5 U.S. nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)
    • 9.2.3 Canada
      • 9.2.3.1 Canada nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
      • 9.2.3.2 Canada nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
      • 9.2.3.3 Canada nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
      • 9.2.3.4 Canada nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
      • 9.2.3.5 Canada nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)
  • 9.3 Europe
    • 9.3.1 Europe market estimates and forecasts, 2017 - 2028 (USD Million)
    • 9.3.2 Germany
      • 9.3.2.1 Germany nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
      • 9.3.2.2 Germany nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
      • 9.3.2.3 Germany nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
      • 9.3.2.4 Germany nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
      • 9.3.2.5 Germany nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)
    • 9.3.3 U.K.
      • 9.3.3.1 U.K. nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
      • 9.3.3.2 U.K. nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
      • 9.3.3.3 U.K. nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
      • 9.3.3.4 U.K. nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
      • 9.3.3.5 U.K. nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific market estimates and forecasts, 2017 - 2028 (USD Million)
    • 9.4.2 Japan
      • 9.4.2.1 Japan nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
      • 9.4.2.2 Japan nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
      • 9.4.2.3 Japan nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
      • 9.4.2.4 Japan nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
      • 9.4.2.5 Japan nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)
    • 9.4.3 China
      • 9.4.3.1 China nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
      • 9.4.3.2 China nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
      • 9.4.3.3 China nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
      • 9.4.3.4 China nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
      • 9.4.3.5 China nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Latin America market estimates and forecasts, 2017 - 2028 (USD Million)
    • 9.5.2 Brazil
      • 9.5.2.1 Brazil nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
      • 9.5.2.2 Brazil nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
      • 9.5.2.3 Brazil nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
      • 9.5.2.4 Brazil nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
      • 9.5.2.5 Brazil nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)
    • 9.5.3 Mexico
      • 9.5.3.1 Mexico nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
      • 9.5.3.2 Mexico nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
      • 9.5.3.3 Mexico nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
      • 9.5.3.4 Mexico nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
      • 9.5.3.5 Mexico nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)
  • 9.6 Middle East and Africa (MEA)
    • 9.6.1 MEA market estimates and forecasts, 2017 - 2028 (USD Million)
    • 9.6.2 South Africa
      • 9.6.3.1 South Africa nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
      • 9.6.3.2 South Africa nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
      • 9.6.3.3 South Africa nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
      • 9.6.3.4 South Africa nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
      • 9.6.3.5 South Africa nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)

Chapter 10 Competitive Landscape

  • 10.1 Company categorization
  • 10.2 Strategy framework
  • 10.3 Competitive Landscape
  • 10.4 Public Companies
    • 10.4.1 Company size
    • 10.4.2 Geographical presence
    • 10.4.3 Product portfolio
    • 10.4.4 Segment coverage
    • 10.4.5 Other factors
  • 10.5 Private Companies
    • 10.5.1 List of key emerging companies
  • 10.6 Company Profiles
    • 10.6.1 QIAGEN
      • 10.6.1.1 Company overview
      • 10.6.1.2 Financial Performance
      • 10.6.1.3 Product benchmarking
      • 10.6.1.4 Strategic initiatives
    • 10.6.2 Thermo Fisher Scientific, Inc.
      • 10.6.2.1 Company overview
      • 10.6.2.2 Financial Performance
      • 10.6.2.3 Product benchmarking
      • 10.6.2.4 Strategic initiatives
    • 10.6.3 Illumina Inc
      • 10.6.3.1 Company overview
      • 10.6.3.1.1 Epicentre (An Illumina Company)
      • 10.6.3.2 Financial performance
      • 10.6.3.3 Product benchmarking
      • 10.6.3.4 Strategic initiatives
    • 10.6.4 Danaher Corporation
      • 10.6.4.1 Company overview
      • 10.6.4.1.1 Beckman Coulter, Inc.
      • 10.6.4.1.2 Cytiva (formerly GE Healthcare)
      • 10.6.4.2 Financial Performance
      • 10.6.4.2.1 Financial Performance: Cytiva
      • 10.6.4.3 Product benchmarking
      • 10.6.4.4 Strategic initiatives
    • 10.6.5 F. Hoffmann-La Roche Ltd.
      • 10.6.5.1 Company overview
      • 10.6.5.2 Financial Performance
      • 10.6.5.3 Product benchmarking
      • 10.6.5.4 Strategic initiatives
    • 10.6.6 Merck KGaA
      • 10.6.6.1 Company overview
      • 10.6.6.1.1 Sigma-Aldrich Co. LLC
      • 10.6.6.2 Financial Performance
      • 10.6.6.3 Product benchmarking
      • 10.6.6.4 Strategic initiatives
    • 10.6.7 Agilent Technologies
      • 10.6.7.1 Company overview
      • 10.6.7.2 Financial Performance
      • 10.6.7.3 Product benchmarking
      • 10.6.7.4 Strategic initiatives
    • 10.6.8 Bio-Rad Laboratories, Inc.
      • 10.6.8.1 Company overview
      • 10.6.8.2 Financial Performance
      • 10.6.8.3 Product benchmarking
      • 10.6.8.4 Strategic initiatives
    • 10.6.9 TAKARA BIO, INC.
      • 10.6.9.1 COMPANY OVERVIEW
      • 10.6.9.1.1 Clontech Laboratories, Inc.
      • 10.6.9.2 FINANCIAL PERFORMANCE
      • 10.6.9.3 PRODUCT BENCHMARKING
      • 10.6.9.4 STRATEGIC INITIATIVES
    • 10.6.10 Promega Corporation
      • 10.6.10.1 Company overview
      • 10.6.10.2 Financial Performance
      • 10.6.10.3 Product benchmarking
      • 10.6.10.4 STRATEGIC INITIATIVES
    • 10.6.11 New England Biolabs
      • 10.6.11.1 Company overview
      • 10.6.11.2 Financial Performance
      • 10.6.11.3 Product benchmarking
      • 10.6.11.4 Strategic initiatives
    • 10.6.12 LGC Limited
      • 10.6.12.1 Company overview
      • 10.6.12.1.1 LGC Biosearch Technologies
      • 10.6.12.2 Financial Performance
      • 10.6.12.3 Product benchmarking
      • 10.6.12.4 Strategic initiatives
    • 10.6.13 Abcam plc
      • 10.6.13.1 Company overview
      • 10.6.13.2 Financial Performance
      • 10.6.13.3 Product benchmarking
    • 10.6.14 Norgen Biotek Corp.
      • 10.6.14.1 Company overview
      • 10.6.14.2 Product benchmarking
      • 10.6.14.3 Strategic initiatives
    • 10.6.15 AUTOGEN. INC.
      • 10.6.15.1 Company overview
      • 10.6.15.2 Financial Performance
      • 10.6.15.3 Product benchmarking
      • 10.6.15.4 Strategic initiatives
    • 10.6.16 Biogenuix
      • 10.6.16.1 Company overview
      • 10.6.16.2 Product benchmarking
      • 10.6.16.3 Strategic initiatives
    • 10.6.17 PCR Biosystems, Inc.
      • 10.6.17.1 Company overview
      • 10.6.17.2 Financial Performance
      • 10.6.17.3 Product benchmarking
      • 10.6.17.4 Strategic initiatives
    • 10.6.18 MagGenome
      • 10.6.18.1 Company overview
      • 10.6.18.2 Product benchmarking
      • 10.6.18.3 Strategic initiatives
    • 10.6.19 Axon Scientific Sdn. Bhd./ Apical Scientific Sdn. Bhd.
      • 10.6.19.1 Company overview
      • 10.6.19.2 Product benchmarking
    • 10.6.20 MACHEREY-NAGEL GmbH & Co. KG
      • 10.6.20.1 Company overview
      • 10.6.20.2 Financial Performance
      • 10.6.20.3 Product benchmarking
      • 10.6.20.4 Strategic initiatives